Company / Shareholders' Equity
Genprex, Inc. Shareholders' Equity History
FY2017-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$7.4M
FY2024
5-year range
$428.6K / $41.3M
FY2020-FY2024
Trend
-66.7%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $41M to $7M over the past 2 years.
Based on SEC 10-K filings.
$7M in FY2024 with a 3-year CAGR of -37.9%.
Declined from $41M to $7M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -37.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -37.9%, indicating a declining trend.
- In FY2024, shareholders' equity decreased 66.7% year-over-year.
- Peak shareholders' equity was recorded in FY2022.
- Lowest shareholders' equity in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -24.42 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $7.4M | -66.7% |
| FY2023 | $22.3M | -46.0% |
| FY2022 | $41.3M | +33.5% |
| FY2021 | $30.9M | +7113.8% |
| FY2018 | $428.6K | -73.6% |
| FY2017 | $1.6M | - |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026